Overview
Cardon co-founded Ziphius Vaccines in 2019 alongside Kristof Vercruysse, Mathieu Ghadanfar, and Tom Almey. The company's saRNA platform allows cells to replicate vaccine instructions and amplify the immune response, enabling significantly lower required doses compared to conventional mRNA vaccines. Ziphius has established manufacturing collaborations with UZ Ghent and Charles River Laboratories, and research partnerships with the University of Antwerp on RNA delivery optimization.
Career history
In the news
Related profiles
This page shows public professional information only, each fact cited. Is this you? send a correction, or ask for removal within 24 hours, no questions asked.